Overview

Lansoprazole in Preterm Infants With Reflux

Status:
Completed

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

Summary

This study is pilot study to evaluate safety and efficacy of lansoprazole in preterm infants with gastroesophageal reflux documented by 24hr pH impedance monitoring

Phase:

Phase 2

Details

Lead Sponsor:

Seoul National University Hospital

Treatments:

Dexlansoprazole
Lansoprazole